Evidence map›Paper›PMID 30133374›Full record

ArticleHealth security

Screening for Anthrax Postexposure Antibiotic Prophylaxis-The New York City Approach.

Mark Misener, David T Starr, Allison J Scaccia, Vibhuti Arya

Open access · hybridAbstract read
In one paragraph

Article in Health security. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mark MisenerMark Misener, MD, is Field Operations Medical Specialist; David T. Starr, MIA, is Assistant Commissioner, Bureau of Emergency Field Operations; and Allison J. Scaccia, NP, is Director, Clinical Planning Unit; all in the Office of Emergency Preparedness and Response, New York City Department of Health and Mental Hygiene, Long Island City, New York. Vibhuti Arya, PharmD, is Associate Clinical Professor, College of Pharmacy and Health Sciences, St. John's University, Queens, New York.
David T StarrMark Misener, MD, is Field Operations Medical Specialist; David T. Starr, MIA, is Assistant Commissioner, Bureau of Emergency Field Operations; and Allison J. Scaccia, NP, is Director, Clinical Planning Unit; all in the Office of Emergency Preparedness and Response, New York City Department of Health and Mental Hygiene, Long Island City, New York. Vibhuti Arya, PharmD, is Associate Clinical Professor, College of Pharmacy and Health Sciences, St. John's University, Queens, New York.
Allison J ScacciaMark Misener, MD, is Field Operations Medical Specialist; David T. Starr, MIA, is Assistant Commissioner, Bureau of Emergency Field Operations; and Allison J. Scaccia, NP, is Director, Clinical Planning Unit; all in the Office of Emergency Preparedness and Response, New York City Department of Health and Mental Hygiene, Long Island City, New York. Vibhuti Arya, PharmD, is Associate Clinical Professor, College of Pharmacy and Health Sciences, St. John's University, Queens, New York.
Vibhuti AryaMark Misener, MD, is Field Operations Medical Specialist; David T. Starr, MIA, is Assistant Commissioner, Bureau of Emergency Field Operations; and Allison J. Scaccia, NP, is Director, Clinical Planning Unit; all in the Office of Emergency Preparedness and Response, New York City Department of Health and Mental Hygiene, Long Island City, New York. Vibhuti Arya, PharmD, is Associate Clinical Professor, College of Pharmacy and Health Sciences, St. John's University, Queens, New York.
New York City Department of Health and Mental Hygiene · USSt. John's University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individuals exposed to spores of B. anthracis must take a course of antibiotics as postexposure prophylaxis (PEP) to prevent inhalation anthrax. During an anthrax event, public health authorities are responsible for conducting dispensing operations to offer PEP to exposed individuals. Jurisdictions have developed antibiotic PEP screening algorithms to determine which antibiotic is appropriate for each individual. Variability exists with regard to screening questions and dispensing decisions based on responses to those questions. It is likely that individuals with similar profiles will receive different antibiotics based solely on the jurisdiction in which they receive their PEP. This lack of consistency among jurisdictions may lead to a loss of confidence in the public health response among the public, the healthcare community, the media, and government leaders, which could compromise the response itself. We present New York City's planning assumptions, screening algorithm, a rationale for our screening questions, and our reasons for excluding screening questions asked by other jurisdictions. We hope that our efforts may assist others in developing and refining their algorithms and associated public messaging and encourage standardization with neighboring jurisdictions where appropriate.

Indexed as

Guidelines as TopicAnthraxAnti-Bacterial AgentsAntibiotic ProphylaxisBacillus anthracisHumansNew York CityPost-Exposure ProphylaxisRespiratory Tract InfectionsAnti-Bacterial Agents

Identifiers

PMID30133374
PMCPMC6340788
OpenAlexW2888687055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.